Fluorinated anthracyclines: synthesis and biological activity

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Fluorine's strategic introduction into biologically active molecules has been a key area in drug design since the 1980s.
• Anthracyclines, used clinically as antitumor drugs since the 1970s, possess significant toxicities that limit their application.
• Recent research has focused on developing anthracycline derivatives with improved profiles, particularly through fluorination.

Purpose of the Study:

• To provide an updated compilation of fluorinated anthracycline compounds.
• To review synthetic strategies for introducing fluorine into anthracycline structures.
• To summarize the biological activities of these novel fluorinated anthracyclines.

Main Methods:

• Literature review of scientific publications on fluorinated anthracyclines.
• Analysis of synthetic routes for incorporating fluorine atoms into aglycon and/or sugar moieties.
• Compilation and summarization of reported biological and antitumor activities.

Main Results:

• Numerous fluorinated anthracycline derivatives have been synthesized and characterized.
• Fluorine substitution has been achieved on both the aglycon and sugar parts of the anthracycline molecule.
• Preliminary data suggests potential for modified or enhanced biological activity in some fluorinated analogs.

Conclusions:

• Fluorination represents a promising strategy for modifying anthracycline properties.
• This review consolidates current knowledge on fluorinated anthracyclines, aiding future drug development.
• Further research into the synthesis and pharmacological evaluation of these compounds is warranted.